X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Middle East and South Asia

FCS Frankfurt Cargo Services receives another important pharma certification

Content Team by Content Team
6th November 2020
in Middle East and South Asia, News
FCS Frankfurt Cargo Services receives another important pharma certification

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Just a few weeks after successfully concluding its IATA CEIV certification, FCS Frankfurt Cargo Services has now also officially received EU “good distribution practice” (GDP) certification for medical products for human use. This marks another important step in the company’s expansion of pharmaceutical logistics activities and ramping up preparations to handle sensitive coronavirus vaccine consignments.

Unlike CEIV certification, which relates exclusively to airfreight, GDP certification is independent of airfreight. It involves checking the quality of the distribution chain for medical goods and ensuring that they are intact all the way from the producer to the end customer according to EU standards.

Claus Wagner, Managing Director of FCS, believes certification is especially significant in light of the growing importance of pharmaceutical logistics. “FCS can offer its customers the very highest, safest and most secure standards for pharmaceutical handling. In our role as a cargo handling company located at the airport, we act as an important interface between air and ground transport with our special warehouses and transshipment processes.”

“We are very proud to have received our GDP certification after having also achieved the CEIV certification recently. FCS is now able to distinguish itself from other service providers. Despite the challenges of this year, my team has been working diligently to ensure FCS is well prepared for pharma handling now and in the future. Our airline customers, as well as the manufacturers and distributors of pharmaceutical products, can plan with confidence that the quality and integrity of their shipments will be maintained throughout the whole FCS supply chain process,” says Markus Schneefuss, Director of Operations at FCS.

A subsidiary of Worldwide Flight Services (WFS), the world’s largest airfreight handling company, FCS and its GDP certification fit into the “Project Coldstream” initiative just recently launched by WFS, which focuses on coordinating worldwide transportation of large delivery quantities of vaccines to fight the COVID-19 virus. According to the International Air Transport Association (IATA), the industry expects these deliveries to amount to the largest volume of airfreight involving a single item ever transported.

The fact that FCS has GDP certification is highly important to Frankfurt Airport, too. With this certification, the company is making a valuable contribution to helping the site prepare optimally for the coming situation.

Previous Post

Delta Cargos new high-tech cooler allows safer transportation of vaccines

Next Post

Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership with Catalent

Related Posts

FDA Accepts BLA for Recommended
FDA Approvals

FDA Accepts BLA for Recommended Biosimilar to Simponi

22nd July 2025
Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
Next Post
Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership with Catalent

Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership with Catalent

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In